18/01/2020 5:53 am Welcome to isteroids.com - BLOG

Friday 12, Nov 2010

  Steroid-Induced Osteoporosis gets better treated with Teriparatide

Posted By
Pin it Share on Tumblr

steroid-induced-osteoporosis-gets-better-treated-with-teriparatideA recent study has determined that glucocorticoid-induced osteoporosis (OP) is now treatable with a synthetic form of the human parathyroid hormone, Teriparatide.

It was found by the researchers that patients with glucocorticoid-induced OP and administered with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.

The findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Sunday 01, Aug 2010

  Steroid-induced osteoporosis is better treated with Teriparatide

Posted By
Pin it Share on Tumblr

Steroid-induced osteoporosis is better treated with TeriparatideForteo or injectable Teriparatide is superior to Fosamax or oral Alendronate, in a head-to-head comparison, for increasing the level of bone mineral density (BMD) by as much as two times, according to investigators.

It was remarked by Philip N. Sambrook, M.D., of the University of Sydney that teriparatide could be considered as a first-line therapy for treating osteoporosis induced by steroids.

Kenneth Saag, M.D., of the University of Alabama at Birmingham and his colleagues said that considerable BMD improvements in the spine and hip regions are possible with Teriparatide.

Sunday 06, Jun 2010

  Alendronate less effective than Teriparatide for steroid-induced osteoporosis

Posted By
Pin it Share on Tumblr

Alendronate less effective than Teriparatide for steroid-induced osteoporosisA recent study has determined that Teriparatide, a synthetic form of the human parathyroid hormone, could be used to effectively treat steroid-induced osteoporosis.

It was found by the involved researchers that osteoporosis patients when treated with teriparatide for a period of 36 months had a greater increase in BMD (bone mineral density) and fewer new vertebral fractures than those treated with alendronate.

The findings of this study were published in an issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Monday 29, Mar 2010

  Steroid-induced osteoporosis gets better treated with Teriparatide

Posted By
Pin it Share on Tumblr

Steroid-induced osteoporosis gets better treated with TeriparatideGlucocorticoid-induced osteoporosis (OP) is better treated with a synthetic form of the human parathyroid hormone, Teriparatide. This finding was disclosed by a recent study. The study findings were published in the November 2009 issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

It was disclosed by the researchers that patients with OP and treated with Teriparatide for a period of 36 months experienced greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.

The measures of this research included changes in lumbar spine and hip bone, BMD, changes in bone biomarkers, fracture incidence, and safety. The 36-month, randomized, double-blind, controlled trial, led by Kenneth Saag, M.D., from the University of Alabama, was conducted at 76 centers located in 13 countries.

Wednesday 27, Jan 2010

  Teriparatide better than Alendronate for treating steroid-induced Osteoporosis

Posted By
Pin it Share on Tumblr

osteoporosisGlucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, which is a synthetic form of the human parathyroid hormone, according to a recent study.

It was found by the researchers that patients with glucocorticoid-induced osteoporosis and treated with teriparatide for a period of 36 months had a significant increase in BMD (bone mineral density) and fewer new vertebral fractures than those treated with alendronate.

The findings of this study were published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Thursday 17, Dec 2009

  Steroid-induced osteoporosis is treatable with Teriparatide

Posted By
Pin it Share on Tumblr

Steroid-induced osteoporosis is treatable with TeriparatideGlucocorticoid-induced osteoporosis (OP) is now very much treatable with Teriparatide, a synthetic form of the human parathyroid hormone, as per a recent study.

The involved researchers found that patients with glucocorticoid-induced osteoporosis and administered with teriparatide for a period of 36 months had a greater increase in bone mineral density apart from fewer new vertebral fractures than those treated with alendronate.

The study findings were published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR). The 36-month randomized, double-blind, and controlled trial was conducted at 76 centers located in 13 countries and led by Kenneth Saag, M.D., from the University of Alabama.

Dr. Saag commented that there are a considerable number of individuals treated regularly with steroids for controlling inflammation that puts them at risk for developing osteoporosis and teriparatide is a safe and effective treatment for patients with steroid-induced osteoporosis.

Saturday 31, Oct 2009

  More effective drug discovered for steroid-induced bone loss

Posted By
Pin it Share on Tumblr

More effective drug discovered for steroid-induced bone lossAlendronate used to be the drug of choice in patients with steroids-induced osteoporosis. Recently, however, researchers discovered that the drug teriparatide can help increase bone density better and is better at reducing incidence of vertebral fractures in osteoporotic patients.

Steroid induced osteoporosis is common among patients taking maintenance drugs like prednisone, prednisolone, dexamethasone and cortisone. These types of steroids are called glucocorticoids. They are hormones that are also produced naturally by the body. It helps reduce inflammation among patients with autoimmune disease. Patients with lupus, rheumatoid arthritis, Crohn’s disease and asthma usually take these types of medicines.

In a study conducted, 428 patients with confirmed osteoporosis were divided into two groups. The first group was given 5 mg of prednisone a day for three consecutive months or more. The second group received 10 mg of alendronate a day with an additional placebo injection. All participants received 1,000mg of calcium everyday and 800 International Units of Vitamin D a day.

Results showed patients who received teriparatide had an 11% increase in bone mineral density while patients who received alendronate and placebo showed a 5.3% increase in their bone mineral density.

Researchers concluded that teriparatide is a more effective and safe treatment for steroid induced osteoporosis